Cardiovascular adverse events during adjuvant endocrine therapy for early breast cancer using letrozole or tamoxifen: safety analysis of BIG 1-98 trial. (Q46903076)
Jump to navigation
Jump to search
scientific article published on 12 November 2007
Language | Label | Description | Also known as |
---|---|---|---|
English | Cardiovascular adverse events during adjuvant endocrine therapy for early breast cancer using letrozole or tamoxifen: safety analysis of BIG 1-98 trial. |
scientific article published on 12 November 2007 |
Statements
Cardiovascular adverse events during adjuvant endocrine therapy for early breast cancer using letrozole or tamoxifen: safety analysis of BIG 1-98 trial (English)
Aron Goldhirsch
Beat Thürlimann
Henning Mouridsen
Aparna Keshaviah
Alan S Coates
Monica Castiglione-Gertsch
Zhuoxin Sun
Louis Mauriac
John F Forbes
Robert Paridaens
Richard D Gelber
Ian Smith
12 November 2007